Research shows that CNTF can alleviate MAFLD, as recombinant CNTF improves obesity-related markers, lowers lipid levels, boosts insulin sensitivity, and significantly reduces liver injury and MAFLD in high-fat diet-induced obese rats (128). This evidence concerns the gene CNTF and obesity due to melanocortin 4 receptor deficiency.